+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Peripheral Vasodilator"

Cardiovascular Drugs Markets in China - Product Thumbnail Image

Cardiovascular Drugs Markets in China

  • Report
  • June 2023
  • 268 Pages
  • China
From
Cardiovascular Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Cardiovascular Drugs Industry Forecasts - China Focus

  • Report
  • June 2023
  • 141 Pages
  • China
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Peripheral vasodilators are a class of cardiovascular drugs used to treat conditions such as hypertension, angina, and congestive heart failure. These drugs work by relaxing the smooth muscle cells in the walls of the arteries, allowing for increased blood flow and reduced blood pressure. Commonly used peripheral vasodilators include calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs). Peripheral vasodilators are often used in combination with other drugs, such as diuretics, to treat hypertension. They can also be used to treat angina, a condition in which the heart does not receive enough oxygen-rich blood. In addition, peripheral vasodilators can be used to treat congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. The peripheral vasodilator market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more